Telemedicine and home spirometry in cystic fibrosis: A prospective multicenter study.
children
cystic fibrosis
home spirometry
telemedicine
Journal
Pediatric pulmonology
ISSN: 1099-0496
Titre abrégé: Pediatr Pulmonol
Pays: United States
ID NLM: 8510590
Informations de publication
Date de publication:
04 Jul 2024
04 Jul 2024
Historique:
revised:
11
06
2024
received:
28
12
2023
accepted:
25
06
2024
medline:
4
7
2024
pubmed:
4
7
2024
entrez:
4
7
2024
Statut:
aheadofprint
Résumé
Telehealth and home spirometry feasibility for children has been established, but their impact on cystic fibrosis (CF) disease progression remains unassessed. We aimed to evaluate the effects of telehealth and home spirometry on CF disease progression and care. Children with CF aged 5-17 years from all Swedish CF centers were provided with home spirometers. A minimum of two in-person visits were replaced with telemedicine visits and participants were instructed to conduct home spirometry before visits. Linear mixed-effects models were used to compare annual CF disease trajectories during the intervention period and prepandemic period (1 January 2019 to 28 February 2020). Participants and caregivers completed study questionnaires. A total of 59 individuals completed the study over a mean (SD) period of 6.8 (1.4) months, made 3.1 (1.0) physical visits and 2.2 (0.6) telehealth visits per patient year during the study period. The mean difference (95% CI) between the intervention and prepandemic period progression rate for FEV Combining telehealth and physical visits with access to home spirometry demonstrated comparable effectiveness as exclusively in-person care with enhanced flexibility and personalization of CF care.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Petter Silverskiolds foundation
Organisme : VINNOVA
Informations de copyright
© 2024 The Author(s). Pediatric Pulmonology published by Wiley Periodicals LLC.
Références
Barr HL, Bihouee T, Zwitserloot AM. A year in review: real world evidence, functional monitoring and emerging therapeutics in 2021. J Cyst Fibros. 2022;21(2):191‐196.
Shah AC, Badawy SM. Telemedicine in pediatrics: systematic review of randomized controlled trials. JMIR Pediatr Parent. 2021;4(1):e22696.
Vagg T, Shanthikumar S, Ibrahim H, et al. Telehealth in cystic fibrosis. A systematic review incorporating a novel scoring system and expert weighting to identify a ‘top 10 manuscripts’ to inform future best practices implementation. J Cyst Fibros. 2023;22(4):598‐606.
Beaufils F, Enaud R, Gallode F, et al. Adherence, reliability, and variability of home spirometry telemonitoring in cystic fibrosis. Front Pediatr. 2023;11:1111088.
Fettes E, Riley M, Brotherston S, et al. “You're on mute!” Does pediatric CF home spirometry require physiologist supervision? Pediatr Pulmonol. 2022;57(1):278‐284.
Ranganathan SC. Evaluating barriers to and promotors of telehealth during the COVID‐19 pandemic at U.S. cystic fibrosis programs (Commentary). Jo Cyst Fibros. 2021;20(suppl 3):14‐15.
Berlinski A, Leisenring P, Willis L, King S. Home spirometry in children with cystic fibrosis. Bioengineering. 2023;10(2):242.
Edmondson C, Westrupp N, Short C, et al. Unsupervised home spirometry is not equivalent to supervised clinic spirometry in children and young people with cystic fibrosis: results from the CLIMB‐CF study. Pediatr Pulmonol. 2023;58(10):2871‐2880.
Nelson EC, Eftimovska E, Lind C, Hager A, Wasson JH, Lindblad S. Patient reported outcome measures in practice. BMJ. 2015;350:g7818.
Van Citters AD, Dieni O, Scalia P, et al. Barriers and facilitators to implementing telehealth services during the COVID‐19 pandemic: a qualitative analysis of interviews with cystic fibrosis care team members. J Cyst Fibros. 2021;20(suppl 3):23‐28.
Culver BH, Graham BL, Coates AL, et al. Recommendations for a standardized pulmonary function report. An official American Thoracic Society Technical Statement. Am J Respir Crit Care Med. 2017;196(11):1463‐1472.
Quanjer PH, Stanojevic S, Cole TJ, et al. Multi‐ethnic reference values for spirometry for the 3‐95‐yr age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324‐1343.
Robinson PD, Latzin P, Verbanck S, et al. Consensus statement for inert gas washout measurement using multiple‐ and single‐breath tests. Eur Respir J. 2013;41(3):507‐522.
Quittner AL. Measurement of quality of life in cystic fibrosis. Curr Opin Pulm Med. 1998;4(6):326‐331.
Somerville LAL, List RP, Compton MH, et al. Real‐world outcomes in cystic fibrosis telemedicine clinical care in a time of a global pandemic. Chest. 2022;161(5):1167‐1179.
Principi N, Autore G, Ramundo G, Esposito S. Epidemiology of respiratory infections during the COVID‐19 pandemic. Viruses. 2023;15(5):1160.
Rimbaldo K, Frayman KB, Shanthikumar S. The impact of telehealth based care on paediatric cystic fibrosis outcomes. J Cyst Fibros. 2023;22(4):706‐709.
Paynter A, Khan U, Heltshe SL, Goss CH, Lechtzin N, Hamblett NM. A comparison of clinic and home spirometry as longtudinal outcomes in cystic fibrosis. J Cyst Fibros. 2022;21(1):78‐83.
Noth I, Cottin V, Chaudhuri N, et al. Home spirometry in patients with idiopathic pulmonary fibrosis: data from the INMARK trial. Eur Respir J. 2021;58(1):2001518.
Curley R, Campbell MJ, Walters SJ, Hoo ZH, Wildman MJ. Regarding the articles on home spirometry. J Cyst Fibros. 2022;21(3):e212‐e214.
Loeb JS, Blower WC, Feldstein JF, Koch BA, Munlin AL, Hardie WD. Acceptability and repeatability of spirometry in children using updated ATS/ERS criteria. Pediatr Pulmonol. 2008;43(10):1020‐1024.
Svedberg M, Gustafsson PM, Robinson PD, Rosberg M, Lindblad A. Variability of lung clearance index in clinically stable cystic fibrosis lung disease in school age children. J Cyst Fibros. 2018;17(2):236‐241.
Taylor‐Robinson D, Whitehead M, Diderichsen F, et al. Understanding the natural progression in %FEV1 decline in patients with cystic fibrosis: a longitudinal study. Thorax. 2012;67(10):860‐866.
Avdimiretz N, Wilson D, Grasemann H. Comparison of a handheld turbine spirometer to conventional spirometry in children with cystic fibrosis. Pediatr Pulmonol. 2020;55(6):1394‐1399.
Bastian‐Lee Y, Chavasse R, Richter H, Seddon P. Assessment of a low‐cost home monitoring spirometer for children. Pediatr Pulmonol. 2002;33(5):388‐394.
Gerzon FLGR, Jöbsis Q, Bannier MAGE, Winkens B, Dompeling E. Discrepancy between lung function measurements at home and in the hospital in children with asthma and CF. J Clin Med. 2020;9(6):1617.
Anand R, McLeese R, Busby J, et al. Unsupervised home spirometry versus supervised clinic spirometry for respiratory disease: a systematic methodology review and meta‐analysis. Eur Respir Rev. 2023;32(169):220248.
Milanzi EB, Koppelman GH, Oldenwening M, et al. Considerations in the use of different spirometers in epidemiological studies. Environ Health. 2019;18(1):39.
Berlinski A. Implementation of pediatric home spirometry: potential height bias. J Cyst Fibros. 2021;20(4):719‐720.
Davis J, Ryan M, Marchetti P, et al. Real‐world feasibility of short‐term, unsupervised home spirometry in CF. Pediatr Pulmonol. 2022;57(12):3129‐3135.
Richardson CH, Orr NJ, Ollosson SL, Irving SJ, Balfour‐Lynn IM, Carr SB. Initiating home spirometry for children during the COVID‐19 pandemic—a practical guide. Paediatr Respir Rev. 2022;42:43‐48.
Compton M, List R, Starheim E, et al. Home spirometry utilisation in telemedicine clinic for cystic fibrosis care during COVID‐19 pandemic: a quality improvement process. BMJ Open Qual. 2021;10(3):e001529.
Dixon E, Dick K, Ollosson S, et al. Telemedicine and cystic fibrosis: do we still need face‐to‐face clinics? Paediatr Respir Rev. 2022;42:23‐28.
Edmondson C, Westrupp N, Seddon P, et al. The feasibility of home monitoring of young people with cystic fibrosis: results from CLIMB‐CF. J Cyst Fibros. 2022;21(1):70‐77.